| Members |
targetComponentId |
| Topical corticosteroid, group III |
Glucocorticoid (substance) |
| Topical corticosteroid, group IV |
Glucocorticoid (substance) |
| Topical corticosteroid, group V |
Glucocorticoid (substance) |
| Topical corticosteroid, group VI |
Glucocorticoid (substance) |
| Topical dermatological preparation adverse reaction |
Adverse reaction to drug |
| Topical dexamethasone allergy |
Allergy to dexamethasone |
| Topical estradiol allergy |
Allergy to estradiol (finding) |
| Topical hydrocortisone allergy |
Allergy to hydrocortisone (finding) |
| Topical prednisolone allergy |
Allergy to prednisolone |
| Topical salicylic acid allergy |
Allergy to salicylic acid (finding) |
| Topical selenium |
Selenium |
| Topical sulfur |
Sulfur |
| Topotecan 1mg powder for infusion solution vial |
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
| Torday's elephant shrew |
Family Macroscelididae |
| Torek operation for orchiopexy |
Orchidopexy |
| Torsemide 10mg/mL injection solution ampule |
Product containing only torasemide in parenteral dose form (medicinal product form) |
| Torulopsis |
Candida |
| Torulopsis candida |
Candida saitoana |
| Torulopsis glabrata |
Nakaseomyces glabratus (organism) |
| Torulopsis pintolopesii |
Candida pintolopesii |
| Total biopterins |
Substance with biopterin structure (substance) |
| Total colectomy, ileostomy and creation of rectal fistula however further qualified |
Total colectomy, ileostomy and rectal mucous fistula |
| Total estimated daily energy intake |
Estimated quantity of intake of energy in 24 hours (observable entity) |
| Total excision of bladder NOS |
Complete cystectomy |
| Total excision of bladder NOS |
Complete cystectomy |
| Total excision of organ NOC |
Complete excision of organ (procedure) |
| Total excision of stomach NOS |
Total gastrectomy |
| Total excision of stomach NOS |
Total gastrectomy |
| Total prosthetic replacement of hip joint not using cement NOS |
Uncemented prosthetic total arthroplasty of hip joint |
| Total prosthetic replacement of hip joint using cement NOS |
Cemented prosthetic total arthroplasty of hip joint (procedure) |
| Total white cell count NOS |
White blood cell count |
| Total white cell count NOS |
White blood cell count |
| Tourette's disorder |
Gilles de la Tourette's syndrome |
| Town planner/architect NOS |
Architect AND/OR town planner |
| Town planner/architect NOS |
Architect AND/OR town planner |
| Toxemia of pregnancy |
Pre-eclampsia (disorder) |
| Toxic effect |
Poisoning |
| Toxic effect from eating shellfish |
Toxic effect from eating shellfish (disorder) |
| Toxic effect from noxious substance eaten as food, NEC |
Food poisoning |
| Toxic effect of chiefly nonmedicinal substance, NEC |
Toxic effect of chiefly nonmedicinal substance |
| Toxic effect of hydrocarbon gas, NEC |
Toxic effect of hydrocarbon gas |
| Toxic effect of nitroderivatives and aminoderivatives of benzene and its homologues |
Poisoning caused by substance with benzene structure (disorder) |
| Toxic effect of non-petroleum-based solvent |
Toxic effect of nonpetroleum-based solvent |
| Toxic effect of noxious substance eaten as food |
Food poisoning |
| Toxic effect of other nonpetroleum-based solvent, NEC |
Toxic effect of nonpetroleum-based solvent |
| Toxic effect of tobacco and nicotine |
Nicotine poisoning |
| Toxic effects - substances NOS |
Poisoning |
| Toxic effects - substances NOS |
Poisoning |
| Toxic encephalopathy |
Toxic encephalopathy |
| Toxic liver disease with acute hepatitis |
Acute toxic hepatitis |
| Toxic liver disease with cholestasis |
Drug-induced intrahepatic cholestasis |
| Toxic nephropathy, not elsewhere classified |
Toxic nephropathy |
| Toxic nephropathy, not elsewhere classified |
Toxic nephropathy |
| Toxic noninfectious hepatitis |
Toxic hepatitis (disorder) |
| Toxic porphyria, NEC |
Porphyria caused by toxic effect of substance (disorder) |
| Toxicology - blood |
Measurement of level of substance in blood (procedure) |
| Toxoplasma hepatitis |
Hepatitis caused by Toxoplasma gondii |
| Toxoplasmosis: [test] or [titre] |
Toxoplasmosis test |
| Toy in nose causing respiratory obstruction |
Obstruction of respiratory tract caused by toy in nose (disorder) |
| Toy or novelty |
Toy |
| Tracheal endoscopy: [diagnostic rigid NOS] or [NEC] |
Endoscopy of trachea using rigid bronchoscope |
| Tracheostomy site |
Tracheostomy stoma |
| Tracheostomy, emergency procedure by cricothyroid membrane approach |
Emergency cricothyroidotomy |
| Traditional therapy |
Complementary therapy |
| Trainee manager NOS |
Trainee manager |
| Trainee manager NOS |
Trainee manager |
| Tramadol hydrochloride 300mg m/r capsule |
Product containing only tramadol in oral dose form (medicinal product form) |
| Tramadol hydrochloride 300mg prolonged-release oral capsule |
Product containing only tramadol in oral dose form (medicinal product form) |
| Tramadol hydrochloride 50mg soluble tablet |
Product containing precisely tramadol hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
| Tramazoline hydrochloride+dexamethasone isonicotinate |
Product containing dexamethasone and tramazoline (medicinal product) |
| Trandolapril allergy |
Non-allergic hypersensitivity to trandolapril (finding) |
| Trandolapril+verapamil hydrochloride |
Product containing trandolapril and verapamil (medicinal product) |
| Trandolapril+verapamil hydrochloride 1mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 1mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/180mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/180mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 2mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 4mg/240mg m/r tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Trandolapril+verapamil hydrochloride 4mg/240mg prolonged-release oral tablet |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
| Tranexamic acid 100mg/mL conventional release solution for injection 10mL vial |
Tranexamic acid 100 mg/mL solution for injection |
| Tranexamic acid 100mg/mL injection |
Tranexamic acid 100 mg/mL solution for injection |
| Tranexamic acid 100mg/mL intravenous solution 10mL vial |
Tranexamic acid 100 mg/mL solution for injection |
| Transacylase |
Transacylase |
| Transcarbamoylase |
Transcarbamoylase |
| Transcarboxylase |
Transcarboxylase |
| Transcortin |
Corticotropin binding globulin |
| Transdermal glyceryl trinitrate allergy |
Allergy to nitroglycerin |
| Transesophageal angiography of aorta |
Transesophageal echocardiography of thoracic aorta (procedure) |
| Transfer of forearm tendon or muscle |
Transposition procedure |
| Transfer of pedicle flap graft |
Reconstruction using pedicle skin flap (procedure) |
| Transformiminase |
Transformiminase |
| Transformylase |
Transhydroxymethylase |
| Transfusion medicine service |
Blood transfusion service |
| Transfusion reaction NOS |
Blood transfusion reaction |
| Transfusion reaction caused by specific isoantibody |
Blood transfusion reaction |
| Transfusion reaction due to isoantibody |
Blood transfusion reaction |
| Transhepatic |
Transhepatic approach |
| Transhydroxymethylase |
Transhydroxymethylase |
| Transient |
Transitory |
| Transient cerebral ischaemia NOS |
Transient cerebral ischemia |
FHIR